Triamcinolone Acetonide

"Triamcinolone Acetonide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.

Descriptor ID	D014222
MeSH Number(s)	D04.210.500.745.432.915.715 D04.210.500.908.891.927
Concept/Terms	Triamcinolone Acetonide Triamcinolone Acetonide Acetonide, Triamcinolone Cinonide Cinonide Tricort-40 Tricort-40 Tricort 40 Tricort40 Kenalog Kenalog Kenalog 40 Kenalog 40 Azmacort Azmacort Kenacort A Kenacort A

Below are MeSH descriptors whose meaning is more general than "Triamcinolone Acetonide".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Pregnanes [D04.210.500.745]
Pregnadienes [D04.210.500.745.432]
Triamcinolone [D04.210.500.745.432.915]
Triamcinolone Acetonide [D04.210.500.745.432.915.715]
Steroids, Fluorinated [D04.210.500.908]
Triamcinolone [D04.210.500.908.891]
Triamcinolone Acetonide [D04.210.500.908.891.927]

Below are MeSH descriptors whose meaning is related to "Triamcinolone Acetonide".

Below are MeSH descriptors whose meaning is more specific than "Triamcinolone Acetonide".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Triamcinolone Acetonide" by people in this website by year, and whether "Triamcinolone Acetonide" was a major or minor topic of these publications.

Bar chart showing 38 publications over 20 distinct years, with a maximum of 4 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1999	2	0	2
2000	1	0	1
2003	3	0	3
2005	2	0	2
2006	2	0	2
2007	1	0	1
2008	2	1	3
2009	2	1	3
2011	2	1	3
2013	1	1	2
2014	2	0	2
2015	2	0	2
2016	1	0	1
2017	0	1	1
2018	0	1	1
2020	3	1	4
2021	2	0	2
2023	0	1	1
2024	1	0	1

Below are the most recent publications written about "Triamcinolone Acetonide" by people in Profiles.

Momenaei B, Pandit SA, Wang KY, Wakabayashi T, Hsu J, Regillo CD, Klufas MA, Xu D, Cohen MN, Garg SJ, Kuriyan AE, Yonekawa Y. SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE FOR REFRACTORY POSTOPERATIVE CYSTOID MACULAR EDEMA. Retina. 2024 08 01; 44(8):1379-1386.

View in: PubMed
Bas Z, Sajjadi Z, Shields CL. SARCOID GRANULOMA OF THE CHOROID AND CILIARY BODY IN 50 CASES. Retina. 2023 11 01; 43(11):1842-1851.

View in: PubMed
Watane A, Kalavar M, Yannuzzi NA, Kuriyan AE, Sridhar J. TRENDS IN INTRAVITREAL CORTICOSTEROID AGENT USE BY US OPHTHALMOLOGISTS IN MEDICARE BENEFICIARIES AND ASSOCIATION WITH PHYSICIAN-INDUSTRY INTERACTIONS. Retina. 2021 Aug 01; 41(8):1754-1761.

View in: PubMed
Kuley B, Storey PP, Wibbelsman TD, Pancholy M, Zhang QE, Sharpe J, Bello N, Obeid A, Regillo C, Kaiser RS, Chiang A, Fineman MS, Vander JF, Gupta OP, Spirn MJ, Dunn JP, Mehta S, Park CH, Maguire JI, Garg S. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide. Curr Eye Res. 2021 06; 46(6):824-830.

View in: PubMed
Kuley B, Storey PP, Pancholy M, Bello N, Murphy J, Goodman J, Wibbelsman TD, Obeid A, Chiang A, Regillo C, Garg S. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone. Can J Ophthalmol. 2020 12; 55(6):480-485.

View in: PubMed
Kuley B, Storey PP, Pancholy M, Obeid A, Murphy J, Goodman J, Wibbelsman TD, Regillo C, Chiang A. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone. Semin Ophthalmol. 2020 Feb 17; 35(2):141-146.

View in: PubMed
Bielory L, Gross GN, Letierce A, Melas-Melt L, Lucio L. Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysis. Ann Allergy Asthma Immunol. 2020 06; 124(6):616-621.e3.

View in: PubMed
Storey PP, Obeid A, Pancholy M, Goodman J, Borkar D, Su D, Regillo C. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Retina. 2020 Jan; 40(1):75-79.

View in: PubMed
McMahon JF, Adam MK, Dunn JP. Optical Coherence Tomography and Management of a Retinal Granuloma in Presumed Ocular Sarcoidosis. Ocul Immunol Inflamm. 2019; 27(7):1052-1056.

View in: PubMed
Tyson SL, Bailey R, Roman JS, Zhan T, Hark LA, Haller JA. Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review. Curr Opin Ophthalmol. 2017 Jan; 28(1):73-80.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement